How Much Does Wegovy Cost in 2026?

This guide lives in the PlexusDx Education Hub, our library of evidence-based reading on GLP-1 pathways, weight management, and the genetics behind metabolic decisions.

Wegovy cost is one of the most-searched questions in the GLP-1 landscape, and the reason quoted prices vary so much is that no single figure captures what any given patient pays. The published list price is a ceiling, not a checkout total. Below, we start with that anchor number, then work through the four variables that move it: coverage, savings programs, pharmacy pricing, and the compounded-alternative pathway.

The list price anchor

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. Very few insured patients pay that. List price is the figure that exists before insurance, rebates, manufacturer savings cards, and pharmacy negotiation are applied, and out-of-pocket cost varies by plan, formulary, prior authorization, and the indication written on the prescription.

How coverage changes the math

Whether a commercial plan covers Wegovy depends on the FDA-approved indication on the prescription and on the plan's formulary and prior authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes. Chronic weight management coverage is more variable, is often gated behind BMI-based prior authorization, and is excluded outright by some plans. As of April 2026, Medicare does not cover FDA-approved weight-management drugs for weight alone, though some products carry cardiovascular-indication coverage. Confirm details directly with your plan.

Savings cards and coupons

Novo Nordisk publishes a manufacturer savings card program that can substantially cut monthly out-of-pocket cost for eligible commercially-insured patients. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and cards carry monthly and annual caps that change over time. Independent discount platforms such as GoodRx and SingleCare publish coupon prices that differ by pharmacy. Verify current terms on the manufacturer site at the time of fill.

The compounded-alternative pathway

During the FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed but did not close the legitimate compounding window. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified. These products are not identical to FDA-approved brand products, are not generics, and are priced separately.

What real-world totals look like

With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. When a plan does not cover the indication, cash-pay cost lands closer to list price minus any coupon. Without insurance, cash pay approaches list price, while compounded options through the PlexusDx Weight Management Protocols carry a separate pricing structure published on each product page.

Where your genetics fit in

Cost is one variable; your underlying biology is another that a price sheet never shows. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, reading pathway-level variants such as FTO, GLP1R, MC4R that shape appetite signaling, energy balance, and baseline metabolic tendencies. It is trait and pathway education only. It does not predict how you will respond to any specific medication, and it is not a drug-response test. Think of it as the biological backdrop your provider reads before any conversation about a protocol.

Why quoted prices vary so widely

Part of the confusion around Wegovy cost is that every number online reflects a different scenario. One person quotes their insured copay, another quotes a cash price at a specific pharmacy, and a third quotes list price without context. None of them is wrong for their situation, but none of them predicts yours. The honest way to read any figure is to ask which lever it assumes: coverage of the indication, a savings card, a pharmacy coupon, or none of the above. Once you know which assumptions sit behind a quoted price, you can judge whether it applies to you. That is why confirming the current figure with your own pharmacy, under your own coverage, beats trusting a headline number from a forum or an ad.

Frequently Asked Questions

How much does Wegovy cost per month?

Wegovy list price is approximately $1,349 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. Insurance, savings cards, and pharmacy pricing can substantially change what a patient actually pays at the counter, so confirm the current figure with the pharmacy before you fill.

Does insurance cover Wegovy?

It depends on the plan, formulary, FDA indication on the prescription, and prior authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while chronic weight management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there savings cards for Wegovy?

Novo Nordisk publishes a manufacturer savings card program for commercially-insured patients who meet eligibility criteria. Independent platforms like GoodRx also list discount prices. Patients with government insurance are typically excluded from manufacturer cards. Check the manufacturer site at the time of fill for the current terms and caps.

Are there lower-cost alternatives to Wegovy?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide at separate price points from the FDA-approved brand products. Compounded products are legally and factually different, not identical and not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with per-protocol pricing published on each product page.